EDGAR Filing Documents for 0001193125-09-170394

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-09-170394

Filing Date

2009-08-10

Accepted

2009-08-10 14:22:07

Documents

Period of Report

2009-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	477088
2	SECOND AMENDMENT OF RIGHTS WITH RESPECT TO EVENTS OF DEFAULT AND ISSUANCE	dex41.htm	EX-4.1	32267
3	SECURITIES EXCHANGE AGREEMENT WITH TANG CAPITAL PARTNERS, LP	dex101.htm	EX-10.1	28969
4	SECURITIES EXCHANGE AGREEMENT WITH THE CONUS FUND L.P.	dex102.htm	EX-10.2	31380
5	SECURITIES EXCHANGE AGREEMENT WITH THE WOLVERINE CONVERTIBLE ARBITRAGE FUND	dex103.htm	EX-10.3	26312
6	AMENDMENT NUMBER TWO TO MASTER SERVICES AGREEMENT	dex104.htm	EX-10.4	6930
7	LETTER OF AGREEMENT WITH THE UNIVERSITY OF CONNECTICUT HEALTH CENTER	dex105.htm	EX-10.5	5216
8	AMENDMENT NUMBER TWO TO LICENSE AGREEMENT	dex106.htm	EX-10.6	13893
9	BINDING LETTER OF INTENT	dex107.htm	EX-10.7	28972
10	CERTIFICATION OF CEO PURSUANT TO SECTION 302	dex311.htm	EX-31.1	9112
11	CERTIFICATION OF CFO PURSUANT TO SECTION 302	dex312.htm	EX-31.2	9112
12	CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906	dex321.htm	EX-32.1	4488
	Complete submission text file	0001193125-09-170394.txt		675153

Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010

Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200

ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)